Method of detection and disease state management for renal diseases
CA 2342897 A1 · Owner: Seiki, Kosuke · Inventors: Uehara, Yoshio; Nakajima, Hiroshi; Hirawa, Nobuhito
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for detecting kidney diseases at the early stage characterized by measuring the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample collected from a subject and comparing the thus measured concentration with the human lipocalin-type prostaglandin D synthase concentration of body fluid samples obtained from healthy subjects; and a method for pathologically controlling kidney diseases characterized by measuring the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample collected from a subject and evaluating the glomerular filtration level of the patient therefrom.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 3, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 3, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 3, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.